InvestorsHub Logo
Followers 35
Posts 6308
Boards Moderated 0
Alias Born 02/09/2015

Re: None

Saturday, 03/14/2015 12:33:26 PM

Saturday, March 14, 2015 12:33:26 PM

Post# of 403047
The big question: how far will stock sink with so so Kevetrin news, or not so good news. Yeah I know, posters say CTIX says it is working "as expected" but early cohort p21 data is not impressive at all. I know, I know: so what ? There is not supposed to be an impressive increase in p21 at those doses, is the answer, certainly . Have to wait and see. For later cohorts, who knows, as there is no data reported. Cannot assume "as expected" means that the new numbers will be good, I don't think. The new numbers for p21 and patient response may turn out not to be as expected, since this info and territory is unknown. I know some of you disagree.

Are they holding back data until move to NASDAQ?

Cannot believe start of phase 3 trials with B will move stock, unless partnership announced too. If CTIX goes it alone for phase 3 these results are far off.

Positive K news, on the other hand, I think, would probably mean that some of the crazy share prices that you see bandied about might be reached. But it is still so far away from real later trial data for K. Nonetheless good news for a very small number of patients would still be very good news.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News